Related Experiment Video

Updated: Aug 26, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

[Proliferation regulation effect of cyclin G1 antisense oligodeoxy-nucleotides with liposomal transfection on HL-60

Jin-Song Jia1, Shi-Rong Xu, Cong-Rong Jia

  • 1Department of Hematology, The Second Hospital, Hebei Medical University, Shijiazhuang 050000, China. jiajsong@mail.com

Zhongguo Shi Yan Xue Ye Xue Za Zhi
|March 3, 2004
PubMed

Insights

Cyclin G1 antisense oligodeoxynucleotide (ASON) effectively inhibits HL-60 leukemia cell proliferation and promotes apoptosis. This targeted approach shows a concentration-dependent effect on leukemia cell growth.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Context:

  • Leukemia, specifically HL-60 cell line, presents a significant challenge in cancer therapy.
  • Targeting specific gene expression, like cyclin G1, is a promising strategy for anti-cancer drug development.

Purpose:

  • To evaluate the efficacy of cyclin G1 antisense oligodeoxynucleotide (ASON) delivered via liposomal transfection in inhibiting HL-60 cell proliferation.
  • To investigate the impact of ASON on cyclin G1 expression at both protein and mRNA levels.
  • To assess the induction of apoptosis in HL-60 cells following ASON treatment.

Summary:

  • Cyclin G1 ASON with liposomal transfection significantly reduced cyclin G1 protein and mRNA expression in HL-60 cells compared to control groups.
  • A concentration-dependent inhibition of HL-60 cell proliferation and colony-forming units (CFU) was observed with increasing ASON concentrations.
  • The study confirmed apoptosis induction in HL-60 cells, demonstrating the anti-leukemic potential of cyclin G1 ASON.

Impact:

  • This research highlights cyclin G1 ASON as a potential therapeutic agent for leukemia.
  • The findings support the development of targeted gene silencing therapies for hematological malignancies.
  • Understanding the mechanism of ASON in leukemia provides a basis for future clinical investigations.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells08:24

Imaging G Protein-coupled Receptor-mediated Chemotaxis and its Signaling Events in Neutrophil-like HL60 Cells

Published on: September 14, 2016

Related Concept Videos

Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.